CompletedEarly Phase 1NCT01676792

SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma

Studying Vulvar intraepithelial neoplasia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Cheng-Kung University Hospital
Principal Investigator: Keng-Fu Hsu, MD, PhD.
National Cheng-Kung University Hospital
Intervention: SR-T100 gel with 2.3% of SM in Solanum undatum plant extract(drug)
Enrollment: 29 target
Eligibility: 20 years · All sexes
Timeline: 2011 – 2013

Study locations (1)

National Cheng Kung University Hospital, Tainan, Taiwan

Collaborators

G&E Herbal Biotechnology Co., LTD

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01676792 on ClinicalTrials.gov

← Back to all trials